The question that needs to be asked, page-19

First 19 Last

Share
Profile

Follow
lakota6

8,823 Posts.

1047

30/09/18

09:47

Post #: 35933834
Share

Originally posted by thejuicer ↑

Imo they should have paid the sign on bonus in cash even allowing for the following. Merely to prevent the bad look from the option they did take.

However, the reasons they may be keeping hold of more of their cash than you guys want them too may be due to the following:

In the last few presentations they have flagged they will likely invest in a blending and canning facility in the not to distant future - there would be uncertainties around cash required as it depends on size, location, buy new or build and if they partner with someone else and to what degree.

In addition, they've already had to invest more in the US market in FY18, and will again in FY19, than originally planned. They say it's due to the opportunity to expand now in a bigger way than thought this time last year. This has pushed back forecast breakeven in the US. This takes more money than originally earmarked even if the long term payoff will be bigger.

The daigou channel, while perhaps not the biggest margin channel for A2M, was most definitely the one that required the least marketing expenditure from the company as the daigou essentially did it for them. With the uncertainty around this channel going forward A2M may be thinking they need to spend more on direct marketing of their China label, via ecommerce and within China for the mother and baby stores, to pick up the slack if volume via the daigou channel is reduced. In other words more marketing dollars are required in China... more than was earmarked 6-12 months ago.

IMO the market is more gun shy on A2M at the moment due to the uncertainty around the CBEC channel regs. Obviously, in the medium to long term, the introduction of China only label via CBEC will be a positive for A2M given they have SAMR approval for a2 Platinum. Problem is the possible short term disruption, not least of which is the lead times associated with ordering a2 Platinum. Having spoken to A2M, they believe China label only labelling via CBEC is one possible outcome but as yet isn't confirmed. This is one uncertainty they don't need when they are trying to manage the supply change and marketing budget efficiently. What this means for FY19 revenue and profit is difficult to determine and hence the market weakness until it's clarified.

Expand

Good post .
I am sure there is some uncertainty around CBEC and China labeling , when ever you deal with China there is always some uncertainty.
A2M announced on 3rd September about the new China rules and the market responded fairly neutrally.
in fact closed just up for the day.
The SP was building nicely , closing Friday 14th at $10.95 , before announcement of CEO selling the SP was about $11.60 , up nearly 6% for the week so no concern then for the CBEC .
Since that announcement the SP is down 12.7%.

A2M Price at posting: $10.24 Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

First 19 Last

(20min delay)
Last $7.14		Change 0.020(0.28%)		Mkt cap ! $5.183B

Open	High	Low	Value	Volume
$7.12	$7.19	$7.11	$3.073M	429.7K

Buyers (Bids)

No.	Vol.	Price($)
15	18747	$7.14

Sellers (Offers)

Price($)	Vol.	No.
$7.15	14325	19

View Market Depth

No.	Vol.	Price($)
18	15378	7.150
21	27484	7.140
15	29812	7.130
12	75125	7.120
9	10517	7.110

Price($)	Vol.	No.
7.160	13379	19
7.170	17866	21
7.180	28120	18
7.190	40580	18
7.200	52098	24

Last trade - 12.56pm 04/06/2024 (20 minute delay)


Last $7.18		Change 0.020 ( 0.87 %)
Open	High	Low	Volume
$7.10	$7.19	$7.10	242453
Last updated 13.12pm 04/06/2024 ?

A2M (ASX) Chart

The question that needs to be asked, page-19

Featured News

Immutep targets $100m for lung cancer drug trial tests

Daily ASX Market Open: Commodity prices to weigh | June 4, 2024

AFT reaches US distribution milestone for Maxigesic Rapid tablets

Drilling doubles gold-copper mineralisation zone at GEO-01 for Antipa

Daily Market ASX Update: Waning profits suppress index | June 4, 2024

Buyers (Bids)

Sellers (Offers)

Featured News

The question that needs to be asked, page-19

Featured News

Top Stories

Immutep targets $100m for lung cancer drug trial tests

Daily ASX Market Open: Commodity prices to weigh | June 4, 2024

AFT reaches US distribution milestone for Maxigesic Rapid tablets

Drilling doubles gold-copper mineralisation zone at GEO-01 for Antipa

Daily Market ASX Update: Waning profits suppress index | June 4, 2024

Buyers (Bids)

Sellers (Offers)

Featured News